COAGULOPATHY
Clinical trials for COAGULOPATHY explained in plain language.
Never miss a new study
Get alerted when new COAGULOPATHY trials appear
Sign up with your email to follow new studies for COAGULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to tame deadly blood clots in sepsis patients
Disease control Recruiting nowThis early-stage study tests a new medicine called BAY 3389934 in 36 adults with sepsis-induced coagulopathy, a condition where the body's response to infection causes dangerous blood clots. Participants are in the ICU and receive the drug through an IV. The main goal is to check…
Matched conditions: COAGULOPATHY
Phase: PHASE1 • Sponsor: Bayer • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New blood test for kids: will it measure up?
Knowledge-focused Recruiting nowThis study looks at how well a new bedside test (TEG 6s) measures blood clotting in healthy children. About 125 kids having planned surgery will give a small blood sample. The goal is to find normal values for children and see if they match published ranges. This is an observatio…
Matched conditions: COAGULOPATHY
Phase: NA • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC